Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxygen Control and Weaning by O2matic to Patients Admitted With an Exacerbation of COPD

NCT03661086 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.

NCT NCT03661086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03661086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxygen Control and Weaning by O2matic to Patients Admitted With an Exacerbation of COPD
Lead sponsor
Hvidovre University Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2018
Completion date
June 30, 2022
Enrollment
157 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation, copd exacerbation acute, hyperoxia, hypoxemia, hypoxia, respiratory failure, respiratory insufficiency